Track record · closed signal

UnitedHealth Group Incorporated (UNH) — closed signal from October 21, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 19, 2026.

Predicted vs. what happened

UNH price · publication thesis → realized outcomesplit-adjusted
$360.38 Published $400.93 Target $331.02 Window close $378.46 Peak
$355.21 – $360.14Entry zone — fair-value band
$360.38Published — price the day we called it
$400.93Target — the price the thesis aimed for
$378.46Peak — highest point inside the window, not a realized return
$331.02Window close — end-of-window price, context only

What happened

Partial

Reached 42% of the predicted growth at its peak, without hitting the target.

Peak price
$378.46
peak on October 28, 2025 — not a realized return
Peak gain
+5%
peak, from the publication price
Window close
$331.02
end-of-window price, context only
Days to target
Window
October 21, 2025 – January 19, 2026

The thesis — published October 21, 2025

Predicted growth
+12%
over the measurement window
Target price
$400.93
the price the thesis aimed for
Entry zone
$355.21 – $360.14
the fair-value band we waited for
Price at publication
$360.38
published October 21, 2025
Confidence
63%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Investors are warming up to UnitedHealth, and a strong quarter from rival Elevance hints the backdrop may help here too. Some signs suggest the recent downtrend is healing. Plan is to buy slowly around the current range, then add only if the price makes higher lows and more people are buying than usual. The 0-3 month aim is a steady climb, backed by Optum's broad services and tight cost control in a defensive business.

Primary drivers

  • Elevance's stronger profits suggest peers like UNH may hold up too
  • Investor mood is improving, and the recent price trend looks healthier
  • Short-term price swings are calming instead of getting more erratic
  • Optum adds steady, varied income that can cushion tougher periods

How it played out

UNH: the target was not reached

Lyra published UNH at 360.38 on 2025-10-21 with a short-term aim of 12% growth to 400.93. The thesis pointed to stronger peer profits at Elevance, better investor mood, a healthier recent price trend, calmer short-term swings, and Optum's broad services and cost control in a defensive business.

Inside the window, UNH rose to a peak of 378.46 on 2025-10-28, a 5% gain. It stayed below the 400.93 target and never reached it. By 2026-01-19, it ended at 331.02. The thesis partially played out early, then missed by the close.

What happened during the window

On October 28, 2025, MarketWatch reported that UnitedHealth posted better-than-expected third quarter earnings and revenue and raised its 2025 adjusted earnings outlook.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.